» Articles » PMID: 38180513

27-Hydroxycholesterol Inhibits Trophoblast Fusion During Placenta Development by Activating PI3K/AKT/mTOR Signaling Pathway

Overview
Journal Arch Toxicol
Specialty Toxicology
Date 2024 Jan 5
PMID 38180513
Authors
Affiliations
Soon will be listed here.
Abstract

Trophoblast cell syncytialization is essential for placental and fetal development. Abnormal trophoblast cell fusion leads to pregnancy pathologies, such as preeclampsia (PE), intrauterine growth restriction (IUGR), and miscarriage. 27-hydroxycholesterol (27-OHC) is the most abundant oxysterol in human peripheral blood synthesized by sterol 27-hydroxylase (CYP27A1) and is considered a critical mediator between hypercholesterolemia and a variety of related disorders. Gestational hypercholesterolemia was associated with spontaneous preterm delivery and low birth weight (LBW) in term infants, yet the mechanism is unclear. In this study, two trophoblast cell models and CD-1 mice were used to evaluate the effects of 27-OHC on trophoblast fusion during placenta development. Two different kinds of trophoblast cells received a dosage of 2.5, 5, or 10 uM 27-OHC. Three groups of pregnant mice were randomly assigned: control, full treatment (E0.5-E17.5), or late treatment (E13.5-E17.5). All mice received daily intraperitoneal injections of saline (control group) and 27-OHC (treatment group; 5.5 mg/kg). In vitro experiments, we found that 27-OHC inhibited trophoblast cell fusion in primary human trophoblasts (PHT) and forskolin (FSK)-induced BeWo cells. 27-OHC up-regulated the expression of the PI3K/AKT/mTOR signaling pathway-related proteins. Moreover, the PI3K inhibitor LY294002 rescued the inhibitory effect of 27-OHC. Inhibition of trophoblast cell fusion by 27-OHC was also observed in CD-1 mice. Furthermore, fetal weight and placental efficiency decreased and fetal blood vessel development was inhibited in pregnant mice treated with 27-OHC. This study was the first to prove that 27-OHC inhibits trophoblast cell fusion by Activating PI3K/AKT/mTOR signaling pathway. This study reveals a novel mechanism by which dyslipidemia during pregnancy results in adverse pregnancy outcomes.

Citing Articles

Supplementation with probiotics co-cultivation improves the reproductive performance in a sow-piglet model by mother-infant microbiota transmission and placental mTOR signaling.

Li S, Lu T, Lin Z, Zhang Y, Zhou X, Li M World J Microbiol Biotechnol. 2024; 41(1):13.

PMID: 39704872 DOI: 10.1007/s11274-024-04222-5.

References
1.
Aplin J, Myers J, Timms K, Westwood M . Tracking placental development in health and disease. Nat Rev Endocrinol. 2020; 16(9):479-494. DOI: 10.1038/s41574-020-0372-6. View

2.
Asghari A, Umetani M . Obesity and Cancer: 27-Hydroxycholesterol, the Missing Link. Int J Mol Sci. 2020; 21(14). PMC: 7404106. DOI: 10.3390/ijms21144822. View

3.
Aye I, Waddell B, Mark P, Keelan J . Oxysterols inhibit differentiation and fusion of term primary trophoblasts by activating liver X receptors. Placenta. 2011; 32(2):183-91. DOI: 10.1016/j.placenta.2010.12.007. View

4.
Bertolotti M, Del Puppo M, Corna F, Anzivino C, Gabbi C, Baldelli E . Increased appearance rate of 27-hydroxycholesterol in vivo in hypercholesterolemia: a possible compensatory mechanism. Nutr Metab Cardiovasc Dis. 2011; 22(10):823-30. DOI: 10.1016/j.numecd.2011.02.009. View

5.
Bolze P, Mommert M, Mallet F . Contribution of Syncytins and Other Endogenous Retroviral Envelopes to Human Placenta Pathologies. Prog Mol Biol Transl Sci. 2017; 145:111-162. DOI: 10.1016/bs.pmbts.2016.12.005. View